Stephen Hoge sold $17M of MRNA stock

Stephen Hoge, President of Moderna, Inc. (MRNA), sold 78,369 shares of MRNA stock worth $17M, per an SEC Form 4 filed Oct 16, 2026.

The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.

The trade happened on Oct 14, 2026, 2 days before it was made public.

MRNA has moved +2.2% since the trade date, from $226.30 to $231.35 (Nov 12, 2026 close).